Literature DB >> 26517766

Shunting in cryptococcal meningitis.

Jacob Cherian1, Robert L Atmar2, Shankar P Gopinath1.   

Abstract

OBJECT Patients with cryptococcal meningitis often develop symptomatic intracranial hypertension. The need for permanent CSF diversion in these cases remains unclear. METHODS Cases of cryptococcal meningitis over a 5-year period were reviewed from a single, large teaching hospital. Sources of identification included ICD-9 codes, operative logs, and microscopy laboratory records. RESULTS Fifty cases of cryptococcal meningitis were identified. Ninety-eight percent (49/50) of patients were HIV positive. Opening pressure on initial lumbar puncture diagnosing cryptococcal meningitis was elevated (> 25 cm H2O) in 33 cases and normal (≤ 25 cm H2O) in 17 cases. Thirty-eight patients ultimately developed elevated opening pressure over a follow-up period ranging from weeks to years. Serial lumbar punctures for relief of intracranial hypertension were performed in 29 cases. Thirteen of these patients ultimately had shunting procedures performed after failing to improve clinically. Two factors were significantly associated with the need for shunting: patients undergoing shunt placement were more likely to be women (5/13 vs 0/16; p = 0.01) and to have a pattern of increasing CSF cryptococcal antigen (10/13 vs 3/16 cases; p = 0.003). All patients re-presenting with mycological relapse either underwent or were offered shunt placement. CONCLUSIONS Neurosurgeons are often asked to consider CSF diversion in cases of cryptococcal meningitis complicated by intracranial hypertension. Most patients do well with serial lumbar punctures combined with antifungal therapy. When required, shunting generally provided sustained relief from intracranial hypertension symptoms. Ventriculoperitoneal shunts are the favored method of diversion. To the authors' knowledge, the present study is the largest series on diversionary shunts in primarily HIV-positive patients with this problem.

Entities:  

Keywords:  HAART = highly active antiretroviral therapy; IRIS = immune reconstitution inflammatory syndrome; cryptococcal meningitis; headache; infection; lumbar puncture; shunt

Mesh:

Year:  2015        PMID: 26517766     DOI: 10.3171/2015.4.JNS15255

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  [Early ventricle-atrium shunts for treating cryptococcal meningitis in children].

Authors:  Shi-Qi Guang; Fang He; Li-Wen Wu; Fei Yin; Jing Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

2.  Predictive Model for Permanent Shunting in Cryptococcal meningitis.

Authors:  Woralux Phusoongnern; Siriluck Anunnatsiri; Kittisak Sawanyawisuth; Amnat Kitkhuandee
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

Review 3.  HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment.

Authors:  Lauren N Bowen; Bryan Smith; Daniel Reich; Martha Quezado; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

4.  Cryptococcus neoformans-astrocyte interactions: effect on fungal blood brain barrier disruption, brain invasion, and meningitis progression.

Authors:  Yeon Hwa Woo; Luis R Martinez
Journal:  Crit Rev Microbiol       Date:  2021-01-21       Impact factor: 7.624

Review 5.  Cryptococcal meningitis: a review for emergency clinicians.

Authors:  Kathryn Marie Fisher; Tim Montrief; Mark Ramzy; Alex Koyfman; Brit Long
Journal:  Intern Emerg Med       Date:  2021-01-09       Impact factor: 3.397

6.  Cryptococcal meningitis presenting as anterior spinal cord syndrome with accessory nerve palsy in immunocompetent patient: A case report.

Authors:  J Javier Cuellar-Hernandez; Carlos Seañez; Ramon Olivas-Campos; Rodrigo Chavez; Paulo M Tabera-Tarello; B Manuel Serna-Roman
Journal:  Surg Neurol Int       Date:  2021-04-19

7.  Geometrical Distribution of Cryptococcus neoformans Mediates Flower-Like Biofilm Development.

Authors:  William Lopes; Mendeli H Vainstein; Glauber R De Sousa Araujo; Susana Frases; Charley C Staats; Rita M C de Almeida; Augusto Schrank; Lívia Kmetzsch; Marilene H Vainstein
Journal:  Front Microbiol       Date:  2017-12-19       Impact factor: 5.640

8.  Noninvasive intracranial pressure monitoring for HIV-associated cryptococcal meningitis.

Authors:  V R Bollela; G Frigieri; F C Vilar; D L Spavieri; F J Tallarico; G M Tallarico; R A P Andrade; T M de Haes; O M Takayanagui; A M Catai; S Mascarenhas
Journal:  Braz J Med Biol Res       Date:  2017-08-07       Impact factor: 2.590

9.  Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis.

Authors:  John W Baddley; George R Thompson; Kristen O Riley; Mary K Moore; Stephen A Moser; Peter G Pappas
Journal:  Open Forum Infect Dis       Date:  2019-05-20       Impact factor: 3.835

10.  Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis.

Authors:  Jia Liu; Zhuo-Lin Chen; Min Li; Chuan Chen; Huan Yi; Li Xu; Feng Tan; Fu-Hua Peng
Journal:  BMC Neurol       Date:  2018-05-01       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.